| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $57.0M | — | -12.0% |
| Cost of Revenue | $15.5M | — | -14.8% |
| R&D Expense | $12.2M | — | -24.0% |
| SG&A Expense | $12.1M | — | -27.8% |
| Operating Income | -$1.8M | — | +89.7% |
| Interest Expense | $8.3M | — | +10.4% |
| Pre-tax Income | -$8.5M | — | +41.3% |
| Income Tax | $325K | — | +194.2% |
| Net Income | -$8.8M | — | +37.5% |
| EPS (Basic) | -$0.73 | — | -386.7% |
| EPS (Diluted) | -$0.73 | — | -204.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $101.5M | +6.8% | -42.4% |
| Accounts Receivable | $29.0M | +7.5% | -2.1% |
| Current Assets | $145.9M | +6.4% | -34.2% |
| Total Assets | $457.6M | +0.6% | -23.3% |
| Current Liabilities | $130.5M | +6.5% | -2.7% |
| Total Liabilities | $509.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $9.5M | — | +408.3% |
| Capital Expenditures | $2.6M | — | -29.7% |
| Investing Cash Flow | -$2.9M | — | +29.7% |
| Financing Cash Flow | $0 | — | +100.0% |
| Free Cash Flow | $6.9M | — | +200.7% |
| -24.1% |
| Stockholders' Equity | -$51.5M | -15.7% | +31.3% |